Document is current
Any future updates will be listed below
-
Authors
Marques, Pedro https://orcid.org/0000-0002-1120-5461
Vasques-Nóvoa, Francisco
Matias, Paula
Vieira, Joana T.
Mavrakanas, Thomas A.
Sharma, Abhinav
Friões, Fernando
Ferreira, João Pedro
-
Funding
Funding for this research was provided by:
Universidade do Porto
- License Information
-
More Information
Article History
Received: 4 March 2024
Accepted: 5 October 2024
First Online: 21 October 2024
Declarations
:
: PM received salary support from an educational grant by Janssen. AS has received support from the Fonds de Recherche Santé Quebec (FRSQ) Junior 1 clinician scholars’ program, Canadian Institute of Health Research (Grant #175095), Roche Diagnostics, Boehringer-Ingelheim, Novartis, Janssen, Novo-Nordisk, Servier, AstraZeneca, and Takeda. TAM received speaker honoraria from Daiichi Sankyo, BMS Canada, Janssen, Astra Zeneca, and Pfizer and has served on advisory boards for Böhringer Ingelheim, Bayer, GSK, and Servier outside the submitted work. He has also received an unrestricted research grant from Astra Zeneca and operational grants from the Kidney Foundation of Canada, the Heart & Stroke foundation of Canada and the Canadian Institute of Health Research. He is receiving salary support from the Fonds de Recherche Quebec Santé (Junior 1 Clinician Scholar Award # 298742) and is supported by a KRESCENT New Investigator Award. JPF has received research support from Boehringer-Ingelheim, AstraZeneca and Novartis, through his institution, the University of Porto. The reminder authors report not having relevant conflicts of interest regarding the content of this manuscript.
